Association of Atrial Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity With the Development of Atrial Fibrillation After Cardiac Surgery

Journal of the American College of Cardiology

Volumn 51, Issue 1, 2008, Pages 68-74

  Kim, Young M ^a   Kattach, Hassan ^a   Ratnatunga, Chandi ^a   Pillai, Ravi ^a   Channon, Keith M ^a   Casadei, Barbara ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HEART RIGHT ATRIUM; HUMAN; LIPID BLOOD LEVEL; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS RHYTHM; STATISTICAL SIGNIFICANCE;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 37449003799     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.085     Document Type: Article

References (29)

1. Aranki S.F., Shaw D.P., Adams D.H., et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 94 (1996) 390-397
2. Mathew J.P., Fontes M.L., Tudor I.C., et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291 (2004) 1720-1729
3. Clermont G., Vergely C., Jazayeri S., et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96 (2002) 80-87
4. Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 (2003) S715-S720
5. Ochoa J.J., Vilchez M.J., Ibanez S., Huertas J.R., Palacio M.A., and Munoz-Hoyos A. Oxidative stress is evident in erythrocytes as well as plasma in patients undergoing heart surgery involving cardiopulmonary bypass. Free Radic Res 37 (2003) 11-17
6. Gaudino M., Andreotti F., Zamparelli R., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 (2003) II195-II199
7. Mihm M.J., Yu F., Carnes C.A., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
8. Carnes C.A., Chung M.K., Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89 (2001) 32e-38e
9. Allessie M., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54 (2002) 230-246
10. Shiroshita-Takeshita A., Schram G., Lavoie J., and Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 110 (2004) 2313-2319
11. Shiroshita-Takeshita A., Brundel B.J.J.M., Lavoie J., and Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69 (2006) 865-875
12. Griendling K.K., Sorescu D., and Ushio Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
13. Kim Y.M., Zhang Y.H., Guzik T.J., et al. A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97 (2005) 629-636
14. Wasowicz W., Neve J., and Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39 (1993) 2522-2526
15. Nightingale A.K., James P.P., Morris-Thurgood J., et al. Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model. Am J Physiol Heart Circ Physiol 280 (2001) H1334-H1339
16. Toivonen H.J., and Ahotupa M. Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. J Thorac Cardiovasc Surg 108 (1994) 140-147
17. Buss H., Chan T.P., Sluis K.B., Domigan N.M., and Winterbourn C.C. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23 (1997) 361-366
18. Guzik T.J., Mussa S., Gastaldi D., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002) 1656-1662
19. Maack C., Kartes T., Kilter H., et al. Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment. Circulation 108 (2003) 1567-1574
20. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108 (2003) 2034-2040
21. Wassmann S., Laufs U., Muller K., et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22 (2002) 300-305
22. Marumo T., Schini-Kerth V.B., Brandes R.P., and Busse R. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension 32 (1998) 1083-1088
23. Wachtell K., Lehto M., Gerdts E., et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point reduction in hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 712-719
24. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114 (2006) 1455-1461
25. Halonen J., Halonen P., Jarvinen O., et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 297 (2007) 1562-1567
26. Vasquez-Vivar J., Kalyanaraman B., Martasek P., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95 (1998) 9220-9225
27. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61 (2004) 461-470
28. Osranek M., Fatema K., Qaddoura F., et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 48 (2006) 779-786
29. Pratico D., Rokach J., Lawson J., and FitzGerald G.A. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids 128 (2004) 165-171